SCHEMBL2222544

SCHEMBL2222544

COc1ccc(S(=O)(=O)c2c[nH]c3ccc(OC(C)C)cc23)cc1NC1CCN(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.46
CYP2D6 P10635 4/20 0.46
DRD2 P14416 2/20 0.45
SLC6A2 P23975 2/20 0.45
HTR2A P28223 2/20 0.45
HTR2C P28335 2/20 0.45
HTR7 P34969 2/20 0.45
HRH1 P35367 2/20 0.45
ADRA1B P35368 2/20 0.45
SLC6A3 Q01959 2/20 0.45
KCNH2 Q12809 2/20 0.45
SLC6A4 P31645 1/20 0.45
MAPT P10636 2/20 0.45
TP53 P04637 1/20 0.40
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223322 0.92 MAPT (0.53) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL2278202 0.90 MAPT (0.44) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL2270255 0.89 MAPT (0.41) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL2222402 0.86 KCNH2 (0.60) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL14353883 0.85 CYP3A4 (0.50) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL2226273 0.84 MAPT (0.48) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL2226307 0.84 KCNH2 (0.49) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL2265862 0.84 HTR6 (0.41) MAPTTP53HTR6
SCHEMBL2223438 0.84 MAPT (0.53) CYP3A4CYP2D6DRD2SLC6A2HTR2A
SCHEMBL2223312 0.84 MAPT (0.56) CYP3A4CYP2D6DRD2SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A CYP3A4 138/4885CYP2D6 24/4885DRD2 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.